Office of Alumni Affairs and Development
25 Shattuck Street
Boston, MA 02115
giving@hms.harvard.edu
Make a Gift →
Translational Research at HMS
“Q-FASTR is dedicated to transforming cutting-edge basic research at HMS into tomorrow’s therapeutics, diagnostics, and related technologies. By championing early ideas and enveloping them with financial and scientific support, we cultivate breakthroughs that have the potential to reshape medicine.” —Ifat Rubin-Bejerano, Harvard Medical School's Senior Director of Translational Research Programs
Ifat Rubin-Bejerano, PhD
Learn More About Q-FASTR →
Established in 2014, the Quadrangle Fund for Advancing and Seeding Translational Research (Q-FASTR) accelerates early-stage research with potential for commercialization and improved health. Q-FASTR links basic discoveries to new therapies by providing funding, project support, and skills development.
Nearly half of Quad labs now seek Q-FASTR backing, fueling a strong culture of therapeutic invention at HMS and helping propel the Therapeutics Initiative forward. Each year, Q-FASTR supports approximately a dozen principal investigators, including Dr. David Corey and Dr. Arlene Sharpe, whose teams are advancing gene therapies for hereditary deafness and autoimmune disease, respectively.